Mount Yale Investment Advisors LLC Buys Shares of 16,526 Alphatec Holdings, Inc. (NASDAQ:ATEC)

Mount Yale Investment Advisors LLC purchased a new position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 16,526 shares of the medical technology company’s stock, valued at approximately $152,000.

A number of other large investors have also made changes to their positions in ATEC. Nisa Investment Advisors LLC grew its position in Alphatec by 973.3% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,669 shares of the medical technology company’s stock worth $43,000 after buying an additional 4,234 shares during the period. XTX Topco Ltd purchased a new stake in shares of Alphatec during the 3rd quarter worth approximately $69,000. Ballentine Partners LLC purchased a new position in Alphatec in the 4th quarter valued at approximately $120,000. Net Worth Advisory Group purchased a new position in Alphatec in the 3rd quarter valued at approximately $76,000. Finally, Tempus Wealth Planning LLC acquired a new position in shares of Alphatec during the 3rd quarter worth $107,000. Hedge funds and other institutional investors own 66.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on ATEC shares. Barclays increased their price objective on shares of Alphatec from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Wednesday, January 22nd. HC Wainwright reissued a “buy” rating and set a $20.00 price objective on shares of Alphatec in a research note on Tuesday, January 14th. Finally, Needham & Company LLC upped their target price on Alphatec from $13.00 to $16.00 and gave the company a “buy” rating in a research note on Monday, January 13th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $17.56.

Insider Activity at Alphatec

In other news, EVP David Sponsel sold 58,283 shares of the company’s stock in a transaction on Monday, January 13th. The stock was sold at an average price of $10.71, for a total transaction of $624,210.93. Following the completion of the sale, the executive vice president now directly owns 502,311 shares in the company, valued at $5,379,750.81. This represents a 10.40 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Patrick Miles sold 6,687 shares of Alphatec stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $12.00, for a total value of $80,244.00. Following the completion of the transaction, the chief executive officer now owns 5,501,715 shares in the company, valued at $66,020,580. The trade was a 0.12 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 65,208 shares of company stock worth $706,835. 22.80% of the stock is currently owned by insiders.

Alphatec Trading Up 5.3 %

Shares of Alphatec stock opened at $12.06 on Thursday. Alphatec Holdings, Inc. has a fifty-two week low of $4.88 and a fifty-two week high of $17.34. The business’s fifty day moving average is $10.05 and its two-hundred day moving average is $8.10. The company has a quick ratio of 1.15, a current ratio of 2.32 and a debt-to-equity ratio of 30.21. The firm has a market cap of $1.71 billion, a PE ratio of -9.42 and a beta of 1.41.

Alphatec Company Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.